These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12812885)

  • 61. Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease.
    Lim JI; Flaxel CJ; LaBree L
    Ann Acad Med Singap; 2006 Mar; 35(3):198-202. PubMed ID: 16625270
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Spotlight on verteporfin in subfoveal choroidal neovascularisation.
    Keam SJ; Scott LJ; Curran MP
    Drugs Aging; 2004; 21(3):203-9. PubMed ID: 14979737
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Photodynamic therapy of subfoveal recurrences after laser photocoagulation of extrafoveal choroidal neovascularization in pathologic myopia.
    Bandello F; Lanzetta P; Battaglia Parodi M; Roman-Pognuz D; Saviano S; Ravalico G
    Graefes Arch Clin Exp Ophthalmol; 2003 Jul; 241(7):567-570. PubMed ID: 12819976
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Photodynamic therapy with verteporfin in Belgian patients with subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Mori R; Kelkar A; De Laey JJ
    Bull Soc Belge Ophtalmol; 2006; (299):57-64. PubMed ID: 16681088
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Photodynamic therapy with verteporfin for choroidal neovascularization associated with retinal pigment epithelial detachment in age-related macular degeneration.
    Pece A; Isola V; Vadalà M; Calori G
    Retina; 2007 Mar; 27(3):342-8. PubMed ID: 17460590
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Treatment of subfoveal choroidal neovascularization in pathologic myopia with photodynamic therapy: outcomes at 1 and 2 years of follow-up].
    El Matri L; Bouraoui R; Merdassi A; Baccouri R; Mghaieth F; Ben Rejeb S; Meddeb S
    J Fr Ophtalmol; 2006 Sep; 29(7):765-70. PubMed ID: 16988626
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia.
    Rinaldi M; Semeraro F; Chiosi F; Russo A; Romano MR; Savastano MC; dell'Omo R; Costagliola C
    Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):529-539. PubMed ID: 27680013
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison between anti-vascular endothelial growth factor therapy and photodynamic therapy for myopic choroidal neovascularization.
    Matsuo M; Honda S; Matsumiya W; Kusuhara S; Tsukahara Y; Negi A
    Eur J Ophthalmol; 2012; 22(2):210-5. PubMed ID: 21534251
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Photodynamic therapy with verteporfin for recurrent choroidal neovascularisation (CNV) following prior argon laser coagulation].
    Gabel-Pfisterer A; Wehner A; Heimann H; Foerster MH; Wachtlin J
    Ophthalmologe; 2005 Jun; 102(6):592-6. PubMed ID: 15662503
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Two-year results of photodynamic therapy for choroidal neovascularization in young patients].
    Fujisato K; Otani A; Sasahara M; Yodoi Y; Aikawa H; Tamura H; Tsujikawa A; Yoshimura N
    Nippon Ganka Gakkai Zasshi; 2008 Sep; 112(9):777-85. PubMed ID: 18833941
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Low-fluence-rate photodynamic therapy to treat subfoveal choroidal neovascularization in pathological myopia. A study of efficacy and safety.
    Besozzi G; Sborgia L; Furino C; Cardascia N; Dammacco R; Sborgia G; Modoni AP; Boscia F
    Graefes Arch Clin Exp Ophthalmol; 2010 Apr; 248(4):497-502. PubMed ID: 19916015
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.
    Chan WM; Lai TY; Wong AL; Liu DT; Lam DS
    Br J Ophthalmol; 2007 Feb; 91(2):174-9. PubMed ID: 16987898
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effects of photodynamic therapy using verteporfin on experimental choroidal neovascularization and normal retina and choroid up to 7 weeks after treatment.
    Husain D; Kramer M; Kenny AG; Michaud N; Flotte TJ; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2322-31. PubMed ID: 10476799
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Photodynamic therapy for choroidal neovascularisation secondary to basal laminar drusen.
    Guigui B; Martinet V; Leveziel N; Coscas G; Soubrane G; Souied EH
    Eye (Lond); 2009 Nov; 23(11):2115-8. PubMed ID: 19798112
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bilateral CNV associated with optic nerve drusen treated with photodynamic therapy with verteporfin.
    Silva R; Torrent T; Loureiro R; Travassos A; de Abreu JR
    Eur J Ophthalmol; 2004; 14(5):434-7. PubMed ID: 15506607
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy.
    Spaide RF; Freund KB; Slakter J; Sorenson J; Yannuzzi LA; Fisher Y
    Retina; 2002 Oct; 22(5):545-9. PubMed ID: 12441718
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Photodynamic therapy with verteporfin in paediatric and young adult patients: long-term treatment results of choroidal neovascularisations.
    Lipski A; Bornfeld N; Jurklies B
    Br J Ophthalmol; 2008 May; 92(5):655-60. PubMed ID: 18356263
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Outcomes in verteporfin photodynamic therapy for choroidal neovascularisation--'beyond the TAP study'.
    Barnes RM; Gee L; Taylor S; Briggs MC; Harding SP
    Eye (Lond); 2004 Aug; 18(8):809-13. PubMed ID: 14963483
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Changes in confocal indocyanine green angiography through two years after photodynamic therapy with verteporfin.
    Schmidt-Erfurth UM; Michels S
    Ophthalmology; 2003 Jul; 110(7):1306-14. PubMed ID: 12867383
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.